Insights on Droplet Digital PCR-Based Cellular Kinetics and Biodistribution Assay Support for CAR-T Cell Therapy

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• Accurate characterization of in vivo cellular kinetics and biodistribution of chimeric antigen receptor T (CAR-T) cells is crucial for assessing toxicity and efficacy in preclinical and clinical studies.
• A standardized assay for quantifying CAR-T cell distribution, expansion, contraction, and persistence is currently lacking, hindering study comparability.

Purpose of the Study:

• To establish a universal and standardized protocol for analyzing CAR-T cell kinetics and biodistribution.
• To overcome limitations in current methods and enhance the comparability of CAR-T cell therapy studies.

Main Methods:

• Development of a duplexing ddPCR protocol to quantify CAR-T transgene and reference gene from mouse blood and tissue genomic DNA.
• Implementation of a high-throughput method for reproducible genomic DNA extraction.
• Intravenous injection of CAR-T cells into immunodeficient mice with human colorectal cancer xenografts, followed by sample collection and analysis using ddPCR and flow cytometry.

Main Results:

• The ddPCR assay demonstrated linear standard curves, acceptable precision and accuracy, and efficient gDNA recovery (60-100%) from blood and tissue homogenates.
• Quantification in both copy/μg gDNA and copy/μL blood units met regulatory requirements.
• The assay allowed for systematic understanding of CAR-T cell expansion and direct comparison with flow cytometry data.

Conclusions:

• A standardized ddPCR assay, incorporating automated gDNA extraction, has been successfully established for evaluating CAR-T cell kinetics and biodistribution.
• This protocol provides a reliable and reproducible method for CAR-T cell therapy research, improving data comparability and supporting toxicity and efficacy assessments.